92.54
                                            前日終値:
              $92.35
            開ける:
              $91.74
            24時間の取引高:
                426.98K
            Relative Volume:
              0.79
            時価総額:
                $907.13M
            収益:
              -
            当期純損益:
              -
            株価収益率:
              -
            EPS:
                -
            ネットキャッシュフロー:
                -
            1週間 パフォーマンス:
              +0.12%
            1か月 パフォーマンス:
              +2.41%
            6か月 パフォーマンス:
                +3.44%
            1年 パフォーマンス:
              +1.35%
            Vaneck Pharmaceutical Etf Stock (PPH) Company Profile
PPH を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS | 
|---|---|---|---|---|---|---|
|   
                          
                                PPH
                            
                             Vaneck Pharmaceutical Etf | 92.54 | 907.13M | 0 | 0 | 0 | 0.00 | 
|   
                          
                                VTI
                            
                             Vanguard Total Stock Market Etf | 335.42 | 417.53B | 0 | 0 | 0 | 0.00 | 
|   
                          
                                SPY
                            
                             Spdr S P 500 Etf Trust | 682.06 | 372.57B | 0 | 0 | 0 | 0.00 | 
|   
                          
                                IVV
                            
                             Ishares Core S P 500 Etf | 685.23 | 253.41B | 0 | 0 | 0 | 0.00 | 
|   
                          
                                VB
                            
                             Vanguard Small Cap Etf | 254.99 | 160.59B | 0 | 0 | 0 | 0.00 | 
|   
                          
                                QQQ
                            
                             Invesco Qqq Trust Series 1 | 629.07 | 124.43B | 0 | 0 | 0 | 0.00 | 
Vaneck Pharmaceutical Etf (PPH) 最新ニュース
Eli Lilly Extends Lead In $150B Obesity Drug Race As Novo, Pfizer Clash — Here's How ETFs Stand To Gain - Benzinga
PPH: The Big Pharma ETF (NASDAQ:PPH) - Seeking Alpha
Is VanEck Pharmaceutical (PPH) the Best Healthcare ETF to Buy? - Insider Monkey
Drug Stocks Just Had Their Best Week in 2 Decades. Should You Invest? - sharewise.com
Should You Invest in the VanEck Pharmaceutical ETF (PPH)? - MSN
4 Reasons to Buy Pharma ETFs Now for a Healthy Portfolio - The Globe and Mail
Pharmaceutical ETF on track for best week since 2020 - MarketWatch
VanEck Pharmaceutical ETF (NASDAQ:PPH) Sees Unusually-High Trading Volume Following Dividend Announcement - Defense World
Headlines Boost Pharma Stocks. Charts of Pfizer, Johnson & Johnson, Jazz Pharmaceuticals Speak to Rally Into Year End - MSN
Headlines Boost Pharma Stocks. What the Charts of Pfizer, Johnson & Johnson, Jazz Pharmaceuticals Say - Barron's
Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk - inkl
Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms - Benzinga
Big Pharma rebounds despite Trump’s latest tariff threat - Seeking Alpha
Biopharma Stocks Rally After Trump Threatens 100% Pharmaceuticals Tariff - inkl
President Trump's 100% Tariff Threat: What It Means For Your Pharma Portfolio - Seeking Alpha
Trump Slams 100% Tariff on Imported Drugs: Pharma ETFs Take a Hit - The Globe and Mail
PPH: Excellent Pharmaceutical ETF, But Bad Timing To Invest (NASDAQ:PPH) - Seeking Alpha
How Trump's Drug Pricing Policies Could Trigger An Epic Pharma Collapse - Seeking Alpha
Belpointe Asset Management LLC Takes $528,000 Position in VanEck Pharmaceutical ETF $PPH - Defense World
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now? - sharewise.com
Mark Cuban Exposes How Wholesalers Force Pharmacies Into Near-Exclusive Deals, Detailing PBMs' 'Stranglehold' On Drug Pricing - Benzinga
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? - sharewise.com
Pharma stocks higher as Trump backs down from 250% tariff threat - Seeking Alpha
NVO Wins FDA Approval for MASH Treatment: ETFs Likely to Gain - The Globe and Mail
LPL Financial LLC Cuts Position in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
4. SPDR S&P Pharmaceuticals ETF (ARCA:XPH) - Investing News Network
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
ETFs in Focus on Eli Lilly's Solid Q2 Earnings, Weak Obesity Data - The Globe and Mail
Markets Shrug as Chip and Pharma Stocks Navigate Trump's New Tariff Blitz - Money Morning
Envestnet Asset Management Inc. Reduces Stock Holdings in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Cetera Investment Advisers Has $3.16 Million Stake in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Novo Nordisk Shares Plunge, Drag Down Weight-Loss-Drug ETFs - ETF.com
J&J leads big pharma higher after earnings despite Trump’s latest tariff threat - MSN
ETFs to Gain on JNJ's Solid Q1 Earnings & Upbeat Outlook - MSN
ETFs To Gain On JNJ's Solid Q1 Earnings & Upbeat Outlook - Barchart.com
Vaneck Pharmaceutical Etf (PPH) 財務データ
        Vaneck Pharmaceutical Etf (PPH) の財務データはありません。詳細については、他の銘柄を確認してください。
    
収益
当期純利益
現金流量
EPS
                大文字化:
                 
                  | 
                ボリューム (24 時間):
                 
            
         
                     
                             ストックスクリーナーアプリを入手
                    ストックスクリーナーアプリを入手